MedPAC Report Explores Ways For CMS To Use Cost-Effectiveness Analysis
This article was originally published in The Gray Sheet
Executive Summary
CMS could select certain expensive medical devices, surgical and diagnostic procedures for government-sponsored cost-effectiveness research, according to MedPAC's June report to Congress